XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 25 filers reported holding XENON PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $7,014,000 | +387.1% | 465,200 | +29.2% | 1.78% | +149.0% |
Q1 2017 | $1,440,000 | -53.8% | 360,000 | -11.1% | 0.72% | -61.0% |
Q4 2016 | $3,119,000 | -6.1% | 405,000 | -1.2% | 1.84% | +5.8% |
Q3 2016 | $3,321,000 | +37.3% | 410,000 | 0.0% | 1.74% | +7.5% |
Q2 2016 | $2,419,000 | -13.5% | 410,000 | +2.5% | 1.62% | -7.3% |
Q1 2016 | $2,796,000 | +15.9% | 400,000 | +33.3% | 1.74% | +73.0% |
Q4 2015 | $2,412,000 | +93.0% | 300,000 | +98.3% | 1.01% | +63.9% |
Q3 2015 | $1,250,000 | – | 151,300 | – | 0.62% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ghost Tree Capital, LLC | 790,000 | $12,071,000 | 3.53% |
GREAT POINT PARTNERS LLC | 700,000 | $10,696,000 | 2.49% |
COMMODORE CAPITAL LP | 579,432 | $8,854,000 | 2.33% |
ACUTA CAPITAL PARTNERS, LLC | 417,409 | $6,378,000 | 2.25% |
DAFNA Capital Management LLC | 406,535 | $6,212,000 | 1.65% |
Tri Locum Partners LP | 264,134 | $4,036,000 | 1.60% |
Parkman Healthcare Partners LLC | 311,207 | $4,755,000 | 1.20% |
Ghost Tree Capital, LLC | 250,000 | $3,820,000 | 1.12% |
Nan Fung Group Holdings Ltd | 197,880 | $3,024,000 | 0.97% |
BVF INC/IL | 1,571,778 | $24,017,000 | 0.94% |